Department of Medicine, Hadassah University Hospital

Jerusalem 12000

1 studies enrolling now · 4 studies all time

What they study most

Cardiovascular Disease With Mention of Arteriosclerosis, Cardiovascular Diseases, Cardiovascular Risk Factor, Cardiovascular Stroke, Elevated Cholesterol, Familial Hypercholesterolemia, Heterozygous Familial Hypercholesterolemia, Homozygous Familial Hypercholesterolemia, Hypercholesterolemia

Studies at this site

• Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction — Enrolling by invitation
• Study to Assess the Efficacy and Safety of LIB003 in HeFH Patients on Oral Lipid Therapy Needing Further LDL-C Reduction — Completed
• Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reduction — Status unconfirmed
• Phase 3 Study to Evaluate the Efficacy and Safety of LIB003 With Evolocumab in HoFH — Completed